Aardvark Therapeutics, Inc. Common Stock AARD Ratios & Valuation
| FY'25 | ||
|---|---|---|
| Returns | ||
| Return on assets | -59.2%— | |
| Efficiency | ||
| Asset turnover | 0×— | |
| Liquidity | ||
| Current ratio | 10.6×-4.4× | |
| Quick ratio | 10.6×-4.4× | |
| Cash ratio | 4.5×-8.1× | |
| Leverage | ||
| Debt-to-equity | 0×— | |
| Debt-to-assets | 0×0.0× | |
| Per Share | ||
| Book value per share | $5.43+140% | |
| Valuation | ||
| Market capitalization | $124.35M-58.6% | |
| Enterprise value | $62.25M-77.4% | |
| Price / book | 1.4×-0.8× | |
| Free cash flow yield | -19%— | |
| Earnings yield | -56.2%-44.0pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Aardvark Therapeutics, Inc. Common Stock's ratios come from?
- Every ratio is computed from Aardvark Therapeutics, Inc. Common Stock's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.